Aurobindo Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?
AUROBINDO has four hundred and eighty-six approved drugs.
There are nineteen tentative approvals on AUROBINDO drugs.
Summary for Aurobindo
US Patents: | 0 |
Tradenames: | 367 |
Ingredients: | 341 |
NDAs: | 486 |
Patent Litigation for Aurobindo: | See patent lawsuits for Aurobindo |
PTAB Cases with Aurobindo as petitioner: | See PTAB cases with Aurobindo as petitioner |
Drugs and US Patents for Aurobindo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma Ltd | BREXPIPRAZOLE | brexpiprazole | TABLET;ORAL | 213659-002 | Nov 2, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Aurobindo Pharma Usa | CILOSTAZOL | cilostazol | TABLET;ORAL | 077019-001 | Nov 23, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Aurobindo Pharma | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065517-001 | Nov 6, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aurobindo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AUROBINDO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.